New study reports cost-effective, rapid and easy to perform RT-PCR-based method for the detection of SARS-CoV-2, the virus termed COVID-19.
Advancing novel biomarker identification: Thermo Fisher Scientific collaborate with Owlstone Medical
Thermo Fisher Scientific (MA, USA) have announced a collaborative partnership with Owlstone Medical (Cambridge, UK). The partnership will work towards the advancement of early cancer and disease diagnosis through the discovery and validation of novel biomarkers.
Drug discovery and development company, Evotec (Hamburg, Germany), enter a new collaboration agreement with Asia’s largest pharmaceutical company, Takeda (Tokyo, Japan), which promises to discover clinical candidates across multiple therapeutic areas.
Thermo Fisher Scientific (MA, USA) and Cedars-Sinai (CA, USA) announce a collaboration that promises to develop robust, sensitive and reliable LC—MS based workflows for clinical research applications.
Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
Collaboration in action: Nepali chemist receives 10 week bioanalytical training at three Dutch CRO’s
A Chemist and Quality Control Manager from a Nepali pharmaceutical company receives full training in bioanalytical method development and validation.
Amgen and Simcere announce collaboration in the development and distribution of biosimilars in China
An exclusive agreement between Amgen and Simcere has been announced in the co-development and commercialization of four undisclosed oncology and inflammation biosimilars.
Thermo Fisher Scientific announces collaboration with SRI International to advance small molecule research
Thermo Fisher Scientific announces collaboration with SRI International, incorporating SRI International’s BioCyc database collection to the Thermo Scientific Compound Discoverer 2.1 software platform.
Pharmaceutical Product Development (PPD) announces fifth renewal of contract with National Institutes of Health
Pharmaceutical Product Development, LLC has secured its renewal of a fifth contract with National Institutes of Health for HIV research support.
A multi-million pound research center specializing in biomedical research has been opened by SCIEX and the University of Manchester. The research facility will pilot a course of biomarker development projects that will help advance understanding of biomarkers in health and disease.